Functional Precision Medicine Successfully Guides Therapeutic Regimen of ‘Cancer of Unknown Primary’ Later Classified as Triple-Negative Breast Cancer: A Case Report

Functional Precision Medicine Successfully Guides Therapeutic Regimen of ‘Cancer of Unknown Primary’ Later Classified as Triple-Negative Breast Cancer: A Case Report

Introduction: Controlled randomized trials, molecular analytics, and guideline recommendations have so far been irreplaceable tools to ensure appropriate treatment and decision-making for physicians and patients. Individual patient models are increasingly complementing these methods, particularly in...

Full description

Bibliographic Details
Main Authors: Larissa Ruhe, Sonja Heibl, Manfred Czompo, Johannes Haybaeck, Jürgen Loskutov, Manuela Johanna Regenbrecht, Josef Thaler, Lena Wedeken, Christian René Alexander Regenbrecht
Format: Article
Language:English
Published: Karger Publishers 2024-03-01
Series:Case Reports in Oncology
Subjects:
patient-derived organoids
drug sensitivity test
drug screening
unknown primary
triple-negative breast cancer
Online Access:https://beta.karger.com/Article/FullText/538137

Internet

https://beta.karger.com/Article/FullText/538137

Similar Items